UPDATE: Credit Suisse Starts Pear Therapeutics (PEAR) at Outperform (correction)
Tweet Send to a Friend
(Updated - January 20, 2022 4:59 AM EST)
Credit Suisse analyst Judah Frommer initiates coverage on Pear Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse analyst Judah Frommer initiates coverage on Pear Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
